{"organizations": [], "uuid": "cfbd92dd45cfb166fc7db3f59034bdcbd65300d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cesca-therapeutics-entered-amendme/brief-cesca-therapeutics-entered-amendment-to-revolving-line-of-credit-facility-idUSFWN1RV0D1", "country": "US", "domain_rank": 408, "title": "BRIEF-Cesca Therapeutics Entered Amendment To Revolving Line Of Credit Facility", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T13:17:00.000+03:00", "replies_count": 0, "uuid": "cfbd92dd45cfb166fc7db3f59034bdcbd65300d3"}, "author": "", "url": "https://www.reuters.com/article/brief-cesca-therapeutics-entered-amendme/brief-cesca-therapeutics-entered-amendment-to-revolving-line-of-credit-facility-idUSFWN1RV0D1", "ord_in_thread": 0, "title": "BRIEF-Cesca Therapeutics Entered Amendment To Revolving Line Of Credit Facility", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "cesca therapeutics inc", "sentiment": "none"}, {"name": "sec", "sentiment": "none"}, {"name": "credit facility reuters", "sentiment": "none"}, {"name": "cesca therapeutics", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18, 2018 / 10:20 AM / Updated 10 minutes ago BRIEF-Cesca Therapeutics Entered Amendment To Revolving Line Of Credit Facility Reuters Staff 1 Min Read \nApril 18 (Reuters) - Cesca Therapeutics Inc: \n* CESCA THERAPEUTICS SAYS ON APRIL 16, ENTERED AMENDMENT TO ITS REVOLVING LINE OF CREDIT FACILITY - SEC FILING \n* CESCA THERAPEUTICS - WITH AMENDED CREDIT AGREEMENT, ON APRIL 16, CO ENTERED INTO FIRST AMENDED AND RESTATED NOMINATION AND VOTING AGREEMENT \n* CESCA THERAPEUTICS - AMENDED NOMINATION AGREEMENT WILL TERMINATE ACCORDING TO ITS TERMS WHEN AND IF THE BOYALIFE OWNERSHIP PERCENTAGE FALLS BELOW 20% Source text: ( bit.ly/2HID83n ) Further company coverage:", "external_links": [], "published": "2018-04-18T13:17:00.000+03:00", "crawled": "2018-04-18T13:35:28.031+03:00", "highlightTitle": ""}